Loading insider details...
Beta
Latest Form 4 (Feb 9, 2026): Purchase of 300 GALT shares, $810.00.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 9, 2026 | GALECTIN THERAPEUTICS INC (GALT) | Purchase | 300 | $810.00 |
| Jan 21, 2026 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 60,000 | n/a |
| Dec 23, 2025 | GALECTIN THERAPEUTICS INC (GALT) | Purchase | 700 | $2.6K |
| Dec 23, 2025 | GALECTIN THERAPEUTICS INC (GALT) | Purchase | 700 | $2.6K |
| Jul 22, 2025 | GALECTIN THERAPEUTICS INC (GALT) | Purchase | 1,000 | $2.9K |
| Jan 27, 2025 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 60,000 | n/a |
| Dec 26, 2024 | GALECTIN THERAPEUTICS INC (GALT) | Purchase | 13,469 | $11.0K |
| Oct 23, 2024 | GALECTIN THERAPEUTICS INC (GALT) | Purchase | 500 | $1.3K |
| Jul 23, 2024 | GALECTIN THERAPEUTICS INC (GALT) | Purchase | 400 | $956.00 |
| Feb 7, 2024 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 50,000 | n/a |